196 related articles for article (PubMed ID: 9047307)
1. Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors.
Kiefer LL; Ittoop OR; Bunce K; Truesdale AT; Willard DH; Nichols JS; Blanchard SG; Mountjoy K; Chen WJ; Wilkison WO
Biochemistry; 1997 Feb; 36(8):2084-90. PubMed ID: 9047307
[TBL] [Abstract][Full Text] [Related]
2. Melanocortin receptor binding determinants in the agouti protein.
Kiefer LL; Veal JM; Mountjoy KG; Wilkison WO
Biochemistry; 1998 Jan; 37(4):991-7. PubMed ID: 9454589
[TBL] [Abstract][Full Text] [Related]
3. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
Fan W; Boston BA; Kesterson RA; Hruby VJ; Cone RD
Nature; 1997 Jan; 385(6612):165-8. PubMed ID: 8990120
[TBL] [Abstract][Full Text] [Related]
4. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
5. Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells.
Mountjoy KG; Kong PL; Taylor JA; Willard DH; Wilkison WO
Physiol Genomics; 2001 Feb; 5(1):11-9. PubMed ID: 11161002
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Agouti-related protein binding to melanocortin receptors.
Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
[TBL] [Abstract][Full Text] [Related]
7. Agouti protein inhibits growth of B16 melanoma cells in vitro by acting through melanocortin receptors.
Siegrist W; Willard DH; Wilkison WO; Eberle AN
Biochem Biophys Res Commun; 1996 Jan; 218(1):171-5. PubMed ID: 8573126
[TBL] [Abstract][Full Text] [Related]
8. The yellow mouse obesity syndrome and mechanisms of agouti-induced obesity.
Moussa NM; Claycombe KJ
Obes Res; 1999 Sep; 7(5):506-14. PubMed ID: 10509609
[TBL] [Abstract][Full Text] [Related]
9. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors.
Chai BX; Pogozheva ID; Lai YM; Li JY; Neubig RR; Mosberg HI; Gantz I
Biochemistry; 2005 Mar; 44(9):3418-31. PubMed ID: 15736952
[TBL] [Abstract][Full Text] [Related]
10. The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism.
Xue B; Moustaid-N ; Wilkison WO; Zemel MB
FASEB J; 1998 Oct; 12(13):1391-6. PubMed ID: 9761782
[TBL] [Abstract][Full Text] [Related]
11. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome.
Kesterson RA; Huszar D; Lynch CA; Simerly RB; Cone RD
Mol Endocrinol; 1997 May; 11(5):630-7. PubMed ID: 9139806
[TBL] [Abstract][Full Text] [Related]
12. Role of the central melanocortin system in cachexia.
Marks DL; Ling N; Cone RD
Cancer Res; 2001 Feb; 61(4):1432-8. PubMed ID: 11245447
[TBL] [Abstract][Full Text] [Related]
13. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors.
Tota MR; Smith TS; Mao C; MacNeil T; Mosley RT; Van der Ploeg LH; Fong TM
Biochemistry; 1999 Jan; 38(3):897-904. PubMed ID: 9893984
[TBL] [Abstract][Full Text] [Related]
14. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
15. Melanocortin receptors and antagonists regulate pigmentation and body weight.
Jordan SA; Jackson IJ
Bioessays; 1998 Aug; 20(8):603-6. PubMed ID: 9780833
[TBL] [Abstract][Full Text] [Related]
16. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line.
Blanchard SG; Harris CO; Ittoop OR; Nichols JS; Parks DJ; Truesdale AT; Wilkison WO
Biochemistry; 1995 Aug; 34(33):10406-11. PubMed ID: 7544613
[TBL] [Abstract][Full Text] [Related]
17. Agouti regulation of intracellular calcium: role of melanocortin receptors.
Kim JH; Kiefer LL; Woychik RP; Wilkison WO; Truesdale A; Ittoop O; Willard D; Nichols J; Zemel MB
Am J Physiol; 1997 Mar; 272(3 Pt 1):E379-84. PubMed ID: 9124542
[TBL] [Abstract][Full Text] [Related]
18. Agouti: from mouse to man, from skin to fat.
Voisey J; van Daal A
Pigment Cell Res; 2002 Feb; 15(1):10-8. PubMed ID: 11837451
[TBL] [Abstract][Full Text] [Related]
19. Agouti/melanocortin interactions with leptin pathways in obesity.
Zemel MB
Nutr Rev; 1998 Sep; 56(9):271-4. PubMed ID: 9763877
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of melanocortin peptides on neural melanocortin receptors.
Adan RA; Cone RD; Burbach JP; Gispen WH
Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]